UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Eldorado Gold
EGO
$8.37B
| $18.5M | 0.02% |
482,853
-12,833
| -3% | -$393K |
|
|
CLR
677
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $18.1M | 0.02% |
228,438
+7,170
| +3% | +$498K |
|
678
ResMed
RMD
$31.2B
| $18M | 0.02% |
356,485
-145,653
| -29% | -$7.22M |
|
679
Tanger
SKT
$4.68B
| $17.9M | 0.02% |
512,036
-51,074
| -9% | -$1.82M |
|
680
Valmont Industries
VMI
$9.43B
| $17.8M | 0.02% |
116,919
+7,462
| +7% | +$1.15M |
|
|
LVLT
681
DELISTED
Level 3 Communications Inc
LVLT
| $17.7M | 0.02% |
404,124
+30,091
| +8% | +$1.26M |
|
682
Crown Holdings
CCK
$13B
| $17.5M | 0.02% |
352,431
-2,171
| -0.6% | -$104K |
|
683
Rayonier
RYN
$6.48B
| $17.5M | 0.02% |
542,885
-171,730
| -24% | -$5.39M |
|
684
Wolfspeed
WOLF
$1.27B
| $17.2M | 0.02% |
345,284
+40,947
| +13% | +$2.03M |
|
685
Transocean
RIG
$5.7B
| $17.2M | 0.02% |
382,521
+15,676
| +4% | +$667K |
|
|
KOG
686
DELISTED
KODIAK OIL & GAS CORP
KOG
| $17.2M | 0.02% |
1,182,946
-75,744
| -6% | -$985K |
|
687
Vermilion Energy
VET
$1.76B
| $17.2M | 0.02% |
246,287
+22,104
| +10% | +$1.47M |
|
688
Marvell Technology
MRVL
$174B
| $17.1M | 0.02% |
1,194,395
-315,014
| -21% | -$4.85M |
|
689
Kinross Gold
KGC
$27.8B
| $17.1M | 0.02% |
4,115,571
+1,992
| +0% | +$8.1K |
|
|
NUAN
690
DELISTED
Nuance Communications, Inc.
NUAN
| $17.1M | 0.02% |
1,050,742
+126,795
| +14% | +$1.84M |
|
691
Cinemark Holdings
CNK
$4.39B
| $17M | 0.02% |
481,390
+63,882
| +15% | +$1.95M |
|
|
DISCK
692
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $17M | 0.02% |
467,574
-17,164
| -4% | -$629K |
|
|
CBI
693
DELISTED
Chicago Bridge & Iron Nv
CBI
| $16.9M | 0.02% |
247,597
+27,142
| +12% | +$2.16M |
|
694
American Airlines Group
AAL
$10.6B
| $16.9M | 0.02% |
392,611
+324,812
| +479% | +$12.7M |
|
|
YOKU
695
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $16.7M | 0.02% |
699,540
+309,700
| +79% | +$6.95M |
|
696
Darden Restaurants
DRI
$23.6B
| $16.6M | 0.02% |
402,142
-87,407
| -18% | -$3.87M |
|
|
ENDP
697
DELISTED
Endo International plc
ENDP
| $16.6M | 0.02% |
236,888
+156,877
| +196% | +$10.5M |
|
|
EGN
698
DELISTED
Energen
EGN
| $16.5M | 0.02% |
185,141
+16,995
| +10% | +$1.43M |
|
|
BMR
699
DELISTED
BIOMED REALTY TRUST INC
BMR
| $16.5M | 0.02% |
753,683
+79,700
| +12% | +$1.69M |
|
|
SUSS
700
DELISTED
SUSSER HOLDINGS CORPORATION COMMON STOCK
SUSS
| $16.3M | 0.02% |
202,403
-20,028
| -9% | -$1.48M |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.